Skip to content

Author

Mehmet Mutlu Kıdı

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Prognostic Value of Pretreatment Modified Glasgow Prognostic Score in Nivolumab-Treated Advanced Non-Small Cell Lung Cancer

Background/Objectives: Immune checkpoint inhibitors have become a standard treatment option for advanced/metastatic non-small cell lung cancer (NSCLC); however, considerable heterogeneity exists among patients regarding treatment response and survival. This study aimed to determine whether the pretreatment modified Gla...

Sedat Biter, Mehmet Mutlu Kıdı, Yasemin Aydınalp Camadan et al. · 0 citations
Review Open access Sep 2026

Clinicopathological Features, Treatment Modalities, and Prognostic Factors of Leptomeningeal Carcinomatosis in Patients with Breast Cancer: A Single-Center Retrospective Analysis

Aim: Leptomeningeal metastasis (LM) from breast cancer carries a poor prognosis, and most published cohorts originate from high-volume referral centers. We aimed to identify factors associated with overall survival (OS) after an LM diagnosis in routine practice and to describe diagnostic and treatment patterns.Methods:...

Mehmet Mutlu Kıdı, Omer Kaya, Sedat Biter et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.